This study was conducted to assess the clinical advantages of early enteral nutrition (EEN) in pediatric patients who underwent surgery with gastrointestinal (GI) anastomosis.
Introduction
Evidence suggests that postoperative nutritional support could diminish the postoperative complications and ameliorate the clinical outcome in many types of surgical treatment. [1] [2] [3] Specifically, following the major intestinal surgery, early start of enteral nutrition (EN) within the first 24 hours postoperatively is beneficial, such as reduction in infectious complications, bacterial translocation or aspiration, and severity of multiple organ dysfunction syndrome and is even associated with reduced postoperative mortality rate after gastrointestinal (GI) surgery. [4, 5] In addition, EN is suggested to be safer and less expensive than parenteral nutrition (PN). Another benefits of early enteral nutrition (EEN) come from the amelioration oxidative stress after surgery. [6, 7] Therefore, physicians have become interested in feeding patients as soon as possible. Many clinicians continue to feed patients later to the first week for the consideration of the potential risks, hemodynamic instability, which has been considered a relative or absolute contraindication to EEN. Early start of oral nutrition is associated with an increase in splanchnic blood flow. So, it is critical for EN for the hemodynamic condition without an increase in overall cardiac output, termed as the "steal" phenomenon. [8, 9] In patients whose hemodynamic condition is unstable, EN has been related with gut ischemia, which was confirmed in a study of rats with occlusion of the mesenteric artery. [10] Moreover, the benefits of this early approach is not successful per se in all patients and been confirmed in clinical studies. Postoperative total enteral feeding is associated with complications such as postoperative nausea, vomiting, diarrhea, abdominal distention, and abdominal cramps, which is often delayed because of these reasons. These symptoms might be worsen with increasing caloric intake, and this often necessitates prolonged gastric decompression and enteral nutritional support, even lead to discontinuance of enteral feeding. [11, 12] In fact, another valid concern for EEN is the stressing a fresh anastomosis with stools, so a conservative management is still practiced. A considerable proportion of these patients is offered total parenteral nutrition to reach nutritional goals until the passing of flatus or stools during the first week.
Although the EEN has been demonstrated to show several beneficial effects in surgical patients, clinical data in pediatric patients in severe abdominal infection are very limited. Thus, on the basis of our experience and the findings of previous studies, we sought to assess the efficacy of early postoperative EN after surgery in patients with traumatic or nontraumatic GI perforation or strangulation in a retrospective controlled clinical trial.
Materials and methods
The study was designed as a retrospective, single-center review of the clinical records for 484 patients who underwent intestinal anastomosis on emergency or electively laparotomy from January 2007 to December 2012. Computerized medical records were thoroughly reviewed with clinician and nurse notes, surgical records, laboratory tests, imaging examinations, and histopathology results. Specifically, the following variables were recorded in all patients on admission and on days 1, 4, and 8 after surgery: age, body weight, sex, hemoglobin, C-reactive protein (CRP), procalcitonin, and total lymphocyte count. Operating time, intraoperative blood loss, transfusion rate and necessity for reoperation were also recorded. This protocol was approved by the institutional review board of the Chongqing Medical University (IRB, No.: CHMU2011-039) and conducted by the department of surgery, in accordance with the ethical standards prescribed by the Helsinki Declaration of the World Medical Association. Inclusion criteria were patients undergoing primary repair of intestinal perforation, bowel resection and anastomosis, as well as repair of intestinal strangulation and obstruction. Exclusion criteria included patients with postoperative shock and patients with ongoing infection. Additionally, to minimize severity differences in the study population, patients managed in the intensive care unit (ICU) for >3 days were excluded. The primary endpoint of this research, postoperative ileus (POI), was defined as time (in days) to first defecation. Secondary endpoints were clinical outcome, including postoperative complications, and length of hospital stay.
Nutrition care protocol
The patients in this study were managed with same care protocols, including total parenteral nutrition, cessation of enteral feeding. The nasogastric tubes (Flocare Nutricia Ltd., 140-cm long) were inserted into the first jejunal loop through the nose.
EEN project depended on the patient condition and physician's preference because some physicians in our institution considered that it might be safe and beneficial and to promote the recovery of GI function. On postoperative day (PID) 1, ambulation was encouraged; Postoperatively, all patients were allowed to drink and eat as soon as possible. Liquids and solid food were usually offered in proper order from POD 1 to 2 to progress to normal diet on the basis of tolerance. If kept in place after surgery, the nasogastric tube was removed 24 hours after surgery. According to standard care protocols, patients received parenteral nutrition though a central venous catheter in the jugular vein. Total parenteral nutrition (TPN) was given 24 h/d from the first day after surgery for 3 days. The nitrogen intake was 0.25 g/kg body weight per day, caloric intake was 125.4 kJ/kg/d and lipid intake was 1.1 g/kg/d. Usually, TPN was offered to reach nutritional goals 24 h/d for the first 3 days postoperatively, which was set as late enteral nutrition (LEN) group.
Medical reasons, adverse events, or patient's wishes could cause deviation to the protocol and were recorded. Pocrustic agents, probiotics, or atropine, when appropriate, were symptomatically used for diarrhea and abdominal cramping or bloating. Other adverse symptoms were managed as indicated clinically. The PN solutions were prepared under aseptic conditions according to the weight of each patient by a clinical pharmacist. The nutrition mixture was administered via a central venous catheter, including amino acids, fat emulsion, dextrose, electrolytes, vitamins, and trace elements.
The target energy requirements were divided into <80% or ≥80% of goal calorie within 3 to 5 days after initiation EN alone or in combination with supplemental PN.
Clinical assessment
Daily registrations of postoperative GI symptoms, including abdominal bloating, abdominal cramps, intake, diarrhea (defined as more than three bowel movements per day), nausea, vomiting, gastric retention, and defecation, were recorded within the first 5 days. Before the hospital stay, >1 episode of nausea or vomiting was defined as early ileus. We described the surgical outcomes, including ventilator rates, ICU-stay rates, and total lengths of hospital stay (the number of days from the day of operation until the date of discharge) and most common postoperative complications, including complication rates, complication types, such as wound infection, intra-abdominal or pelvic abscesses, anastomotic leaks, and the number of reoperations. Wound complications consisted of wound dehiscence, erythema, swelling, and pus. Infectious complications were confirmed with microbiological analyses and positive cultures. 
Statistical analysis
To minimize the biases in patient selection, propensity score (PS) matching was accomplished using a multivariable logistic regression model. 
Results

Patient characteristics
At the time of the analysis, a total of 575 pediatric patients were eligible for analysis according to the intention-to-treat principle. Among them, 278 (48.3%) received EEN and 297 (51.7%) did not. The baseline features of the pediatric patients according to EEN or LEN are shown in Table 1 . With respect to demographic and preoperative clinical data and intraoperative factors, no significant differences were observed between the 2 groups, like causes of operation, operation time, blood loss, CRP at admission, and transfused patients (P > .05). In addition, there were no significant differences in surgical approach between the 2 groups with unmatched and PS-matched patients (Table 1) .
Under PS-matching, 255 patients with EEN were well matched to 255 patients without EEN. The variables entered were very similar and comparable between the patients with EEN and LEN (Table 1) because the values of absolute standardized mean differences reduced from 0.01 to 0.07. Several variables, including postoperative shock, became more comparable after PS-matching (Table 1) . Table 2 illustrates the clinical outcomes based on EEN and LEN. The mean durations of parenteral nutrition were 2.3 ± 1.6 and 3.2 ± 0.7 days for patients with EEN and LEN, respectively (risk ratio [RR], 0.75; 95% confidence interval [CI] 0.41-1.16, P = .002). All types of nutritional support were well tolerated in both groups. In the propensity-matched cohort, the time to first defecation in the EEN group was 3.2 ± 1.4 days, and 3.8 ± 1.0 days in the LEN group, respectively (RR, 0.62; 95% CI, 0.43-1.08, P = .082). In the LEN group, 33.3% (85/255) developed a POI versus 40.8% (104/255) in the LEN group (RR, 0.73; 95% CI, 0.51-1.04, P = .049). POI includes early ileus late and prolonged ileus. Early ileus occurred in 27 patients in the EEN group versus 46 in the LEN group (RR, 0.54; 95% CI, 0.32-0.90, P = .011). No differences were seen for late and prolonged ileus. The enteral feeding-related complications were evaluated with symptoms, including serum electrolyte abnormalities, abdominal distention, abdominal cramps, and diarrhea. There were no differences in the incidence of these symptoms between the 2 groups. These symptoms were alleviated by slowing down the speed of enteral transfusion or by the administration of medications. None of the patients discontinued enteral feeding, and no enteral feeding-related complications were noted in the LEN group. For nutritional variables (albumin and prealbumin, Table 2 ), no significant differences were found between the 2 groups at POD 5. In patients with EEN, CRP returned more distinctively to normal then patients with LEN. On POD 5, a Table 1 Baseline characteristic of eligible population entered into the propensity score matching analysis.
Clinical outcomes
Total population
Propensity matched population Table 2 ).
Postoperative complications
According to established criteria, postoperative complications are summarized in detail in (Table 3) , although there were no statistically significant differences between groups for any of the individual infectious complications.
Follow-up and recurrence rates
All the patients were followed at least 2 months (a half over 6 months of follow-up) and the median follow-up was 8 months (range, 2-29 months). The incidence of constipation in the patients with EEN was significantly lower compared with that in the control (OR, 0.57; 95% CI, 0.31-1.05; P = .037), which was not expected (Table 4) . During the follow-up, the incidence of adhesive small bowel obstruction (ASBO) was lower for patients with laxative administration compared with control, but no significant difference was attained (P = .092). The patients using EEN suffered almost similar hospital readmission compared with the patients who were subjected with LEN (P = .0001). The most common reason for the hospital readmission was surgery-related ASBO. The median time of first recurrence was 3.6 months (range 2.5-12 months) for patients with EEN and 2.8 months Table 3 Postoperative complications in the matched population (x 2 test). Gastrointestinal function and early outcome in the matched population (multivariate logistic regression). 
Discussion
After PS matching to control the confounders of heterogeneity in this multivariate population, the present study demonstrated that EEN within 48 hours from the completion of GI anastomosis can promote rapid postoperative intestinal function recovery (first defecation) in patients undergoing major intestinal surgery and was associated with reduced postoperative complications and lengths of hospital stay. This improvement might result from the redistributes fluid from the interstitium to the enteric cavity spaces, which relieve the postoperative intestinal edema formation. Compared with traditional postoperative feeding practices, EEN was proved with several benefits by previously published meta-analysis, including reduction of the postoperative septic complications, and improvement of glucose tolerance, protein kinetics, and wound healing. [13, 14] In this retrospective review, after adjusting for covariates, the time to first defecation was shorter with EEN after GI anastomosis for pediatric patients. Moreover, despite the minimal degree reduction, EEN was associated with the reduction of postoperative complications and length of hospital stay when compared with LEN. Importantly, EEN was associated with a lower occurrence of anastomotic leakage and reduced readmission rate, which might come from modulating the metabolic and systemic immune response, as well as preserving gut integrity. [15] Another meta-analysis showed that enteral feeding that started within 24 hours after the surgery may be of benefit, such as assisting in a reduction of infection risk or reduction of length of hospital stay. [16] Moreover, postoperative total enteral feeding is associated with complications such as diarrhea, abdominal distention, and abdominal cramps. These symptoms worsen with increasing caloric intake and can lead to discontinuance of enteral feeding. [17] [18] [19] EEN was safe and previously reported detrimental complications, such as ischemia of the small bowel or aspiration pneumonia, were not observed here in this research. On the first 3 days after surgery in this study, the amount of EN increased slowly to avoid severe GI complications. EEN does not negatively affect outcomes of enteral feeding-related complications. Twenty-nine cases in the EEN group had symptoms, like resumption of bowel function, which were alleviated by slowing down the speed of enteral transfusion or by the administration of medications, and none of the patients discontinued enteral feeding or dropped out of the study. There was concern that in the early postoperative phase, caloric target as set by nutritional societies is a matter of dispute for EEN, which should be made up by parenteral supplements to obtain caloric aims. The EEN group received less calories of artificial nutrition than the LEN group, probably associated with the frequent protocol deviations encountered in the EEN group. It is unknown whether the observed effects can be attributed to the caloric intake. In certain patient populations, like intensive care population and acute pancreatitis patients, it was in favor of parenteral nutrition for a reduced mortality rate compared with oral diet nutrition. [20, 21] Owing to its shorter half-life, prealbumin is more sensitive than albumin for evaluating protein synthesis in the liver. In this study, the prealbumin was observed slightly decrease in the EEN groups on the POD 5. Thus, there is clinical evidence in our research supporting the benefits of EEN for pediatric patients, although it is still controversial whether EEN is associated with the reduction synthesis of prealbumin in this specific patient population. The question of whether we underfed the EEN group therefore arises. The issue remains whether possible "underfeeding" in this case is harmful or beneficial. Moreover, to avoid ischemia of the small bowel, EN was not started early in hemodynamically unstable patients. Our results are in accordance to other results of feeding in the ICU: patients receiving lower amounts of feeding recovered better than patients receiving the highest permitted amount of calories. [22] It seems that the amount of calories is not as important as the route and timing of artificial nutrition. Our study has important implications on the nutritional support in pediatric patients and will motivate future studies to conduct adequately powered, randomized controlled clinical trials. The main pillars of enhanced recovery after surgery (ERAS) programs include optimal postoperative pain management and early enteral feeding and mobilization after surgery. ERAS implementation has also resulted a similar reduction in complication rates along with a modest reduction in length of stay (LOS), in different surgical populations in adult patients. [23] The ERAS implementation would be useful to applicability in the paediatric setting.
GI blood flow is reduced in patients after various types of critical illnesses and conditions. Manipulation of the intestine initiates the pathogenesis of intestinal edema, which might be involved in GI blood flow unstable, inflammatory cascade, and activation of macrophages leading to invasion of neutrophils. Many investigators have reported that EN may dampen the inflammatory response and thereby reduce POI, whereas another mechanism may be the stimulation of bowel movements by the input of nutritional liquids. [24, 25] The formation of an inflammatory infiltrate not only impairs motility in the manipulated areas but also leads to generalized hypomotility of the GI tract via activation of inhibitory adrenergic neural pathways. Inhibition of Table 4 Follow-up and recurrence rates in the matched population (x 2 test). Shang et al. Medicine (2018) 97:9 www.md-journal.com the inflammatory response has been shown to be important for reducing POI. [15] Compared with the LEN group, the rate of infectious complication in the EEN group was significantly decreased. [15] In this study, CRP was higher immediately after the operation and recovered better after EN in comparison to the LEN group. Early dampening of this local inflammation via postpyloric nutrition may explain the results found. With regard to anastomotic leakage, the local inflammatory response is also important. EEN may also reduce the inflammatory response and thereby reduce anastomotic leakage. In the experimental setting, EN prevents adverse structural and functional alterations of the anastomotic position by improving the intestinal blood flow, and modulating the systemic and local immune response. [26] EN may also improve splanchnic blood flow and ischemic injury. In fact, although feeding increased GI oxygen consumption, the concomitant increase in oxygen delivery led to better delivery to consumption ratio in the fed versus the unfed state. Histological evidence has proven that EN preserved the gut flora architecture, prevented GI mucosa atrophy, and inhibited microbial translocation from the gut to the blood stream. This hypothesis about effect of EN on splanchnic blood flow or GI oxygen consumption was not investigated in this study, which was suggested in previous research. [27] Although the exact mechanism is difficult to determine in the clinical setting, these results may be explained by an effect of EN on local inflammation and edema recovery.
Our study was limited in several ways. First, it is a retrospective, single-center design analysis, and the decision to initiate EEN was based on intent-to-treat, so not randomly designed. Retrospectively, the days to first defecation were extracted from patient records, which might not be fully accurate. In practice, although there is no executable guideline, possibly, sicker patients were not fed because of their condition, and feeding may simply be a marker of a less ill patient, which might be associated with intestinal edema, long procedure time, more fluid loss, and tend to transfer into ICU care. Also, if a physician is more likely to initiate EN early, he or she would also be more likely to follow other measures to improve outcome or initiatives to decrease rates of health care-associated infection. Owing to the fact that this is a retrospective study, it is not possible to distinguish whether advantageous outcome is simply associated with EN early or a causative factor of awareness of ERAS protocols. Our study does demonstrate that LOS was independently associated with EEN even after controlling for other potential confounders. Lastly, our database does not include any information regarding the type of enteral formulas that patients received, mainly whether they received immune-enhancing formula or standard formula. The study does not take into account patients' total caloric intake, rate of advancement, and whether disruptions in the feeding occurred. Our database did not have enough information regarding the target calorie, protein delivery, and rate of advancement. Therefore, our results need to be carefully interpreted. To limit the influence of confounding variables on the actual effects of EEN, we attempted to control for this possibility by using PS matching to generate comparison groups of patients who had similar baseline factors.
In summary, this comparison of EEN with LEN suggests that the beneficial effect of EEN was embodied in decreasing the POI, infectious complications, and shorten postoperative hospital stay for patients undergoing major intestinal surgery. In addition, we found no evidence of harm because of the EEN. We acknowledge that these results are based on a heterogeneous group of patients, although we performed a PS matching analysis. These results provide justification for an adequately powered, randomized controlled clinical trials in the future to further address this controversial this modality in pediatric patients.
